Former GlaxoSmithKline chief executive Sir Andrew Witty has taken a leave of absence ... although most of those are still in early-stage development. As it stands only three vaccines – one ...
GlaxoSmithKline’s (GSK) former chief executive Andrew Witty was yesterday announced as the new CEO of Optum – a US payer organisation which includes pharmacy benefits manager OptumRx.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback